The buying is concentrated among small-to-mid-size asset managers, not mega-passive funds, which adds conviction. However, the dollar amounts are immaterial relative to market cap, and the 45-day reporting lag means positions may have changed. Watch for insider buying or a catalyst (e.g., clinical data) to confirm the thesis.
IOVA drugs
IOVA drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 4 $8.70entry
- T+1 · 12d ago −11.03%α −6.63% · $7.74
- T+5 · 6d ago −7.01%α −6.10% · $8.09
- T+8 · todayOpen
- T+20 · in 16d Pending
- T+60 · in 3mo Pending
How similar events traded
Executive Summary
Five asset managers increased their IOVA positions in Q3 2026, with Pictet Asset Management and Creative Planning leading the buying. The cluster is entirely active managers, but the total dollar amount is small relative to the company's $3.8B market cap, and there is no insider buying to corroborate the signal.
Key Financial Metrics
Institutional Positions
Net institutional flow: $12.8M
▲ Buyers (5)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Pictet Asset Management Holding | DOUBLED | +867.6% | $6.0M | $5.9M |
| Creative Planning | ADD | +54.7% | $6.5M | $5.3M |
| Strs Ohio | DOUBLED | +232.7% | $1.1M | $966.0K |
| Kestra Advisory Services | ADD | +25.2% | $625.0K | $485.0K |
| Hb Wealth Management | ADD | +35.1% | $270.0K | $214.0K |
Key Facts
- 5 institutional buyers added $12.8M in net new value, with zero sellers in the cluster.
- Pictet Asset Management doubled its stake by 867.6% (value from $179K to $6.0M).
- Creative Planning added 54.7% (value from $1.2M to $6.5M).
- Total buying value of $14.5M is ~0.38% of IOVA's $3.8B market cap.
- No open-market insider buying was detected in the same window (confluence score 34/100).
Financial Impact
5 asset managers accumulated $12.8M in net new IOVA positions during Q3 2026, with total holdings of $14.5M.
Risk Factors
- 13F data is 45+ days stale; positions may have been unwound since quarter-end.
- No insider buying to corroborate the institutional signal.
- Total buying is small relative to market cap, limiting price impact.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-IOVA-2026-Q3 |
Track record
21 reports on IOVA
3 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +121.97% at T+60 after the Jun 10, 2026 report. 5 of 7 went positive at some point.
Filters
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $8.08 settles Dec 9
- Nov 5, 202611d ago 8-K Neutral 4/10 Entry $8.04 settles Dec 7
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $7.74 settles Dec 4
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Viewing Entry $8.70 settles Dec 3
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $8.48 settles Nov 30
- Oct 28, 202619d ago Press Release Bullish 7/10 Entry $9.56 settles Nov 27
- Oct 5, 20266w ago 8-K Neutral 4/10 Entry $12.96 to $8.65 ▼ −33.25% −30.34% vs SPY
- Oct 2, 20266w ago 3 Neutral 2/10 Entry $14.15 to $7.93 ▼ −43.99% −41.42% vs SPY
- Sep 29, 20266w ago 8-K Bullish 6/10 Entry $14.45 to $14.58 ▲ +0.90% +0.19% vs SPY
- Aug 21, 202612w ago Press Release Neutral 2/10 Entry $8.06 to $10.64 ▲ +32.01% +30.70% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers